Revvity, Inc. (RVTY)
151.53
+2.47
(+1.66%)
USD |
NYSE |
Oct 02, 16:00
151.45
-0.08
(-0.05%)
Pre-Market: 20:00
Revvity Enterprise Value : 19.23B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 19.23B |
| October 01, 2026 | 18.95B |
| September 30, 2026 | 19.38B |
| September 29, 2026 | 19.36B |
| September 28, 2026 | 19.17B |
| September 25, 2026 | 19.18B |
| September 24, 2026 | 19.13B |
| September 23, 2026 | 18.18B |
| September 22, 2026 | 18.31B |
| September 21, 2026 | 18.34B |
| September 18, 2026 | 18.32B |
| September 17, 2026 | 18.69B |
| September 16, 2026 | 18.58B |
| September 15, 2026 | 17.96B |
| September 14, 2026 | 16.66B |
| September 11, 2026 | 16.19B |
| September 10, 2026 | 15.81B |
| September 09, 2026 | 16.14B |
| September 08, 2026 | 16.50B |
| September 04, 2026 | 16.85B |
| September 03, 2026 | 16.89B |
| September 02, 2026 | 16.93B |
| September 01, 2026 | 16.44B |
| August 31, 2026 | 16.68B |
| August 28, 2026 | 16.69B |
| Date | Value |
|---|---|
| August 27, 2026 | 16.79B |
| August 26, 2026 | 16.42B |
| August 25, 2026 | 16.25B |
| August 24, 2026 | 16.04B |
| August 21, 2026 | 16.24B |
| August 20, 2026 | 16.17B |
| August 19, 2026 | 15.65B |
| August 18, 2026 | 15.01B |
| August 17, 2026 | 15.28B |
| August 14, 2026 | 15.36B |
| August 13, 2026 | 15.43B |
| August 12, 2026 | 15.47B |
| August 11, 2026 | 15.23B |
| August 10, 2026 | 15.26B |
| August 07, 2026 | 15.11B |
| August 06, 2026 | 15.07B |
| August 05, 2026 | 15.15B |
| August 04, 2026 | 14.75B |
| August 03, 2026 | 15.17B |
| July 31, 2026 | 14.87B |
| July 30, 2026 | 14.99B |
| July 29, 2026 | 14.97B |
| July 28, 2026 | 14.76B |
| July 27, 2026 | 14.38B |
| July 24, 2026 | 14.64B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 280.71B |
| Danaher Corp. | 173.98B |
| Agilent Technologies, Inc. | 49.50B |
| Bio-Rad Laboratories, Inc. | 9.620B |
| Bruker Corp. | 11.29B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 53.48M |
| Revenue (Quarterly) | 729.69M |
| Total Expenses (Quarterly) | 676.21M |
| EPS Diluted (Quarterly) | 0.4642 |
| Gross Profit Margin (Quarterly) | 50.26% |
| Profit Margin (Quarterly) | 7.33% |
| Earnings Yield | 1.39% |
| Operating Earnings Yield | 2.63% |
| Normalized Earnings Yield | 1.853 |